Adult vaccines represent a critical component of preventive healthcare, safeguarding against infectious diseases and reducing the burden of illness in the adult population. In addition to routine vaccines like influenza and Tdap, certain vaccines are tailored to specific age groups and risk factors. The herpes zoster vaccine, for instance, is recommended for adults aged 50 and older to prevent shingles, a painful reactivation of the varicella-zoster virus. The meningococcal vaccine is crucial for adults at increased risk of meningococcal disease, such as college students living in communal settings or those with certain medical conditions. The annual influenza vaccine, recommended for all adults, helps protect against seasonal flu and its potential complications. The importance of travel vaccines, including those for typhoid, yellow fever, and rabies, cannot be overstated for adults planning international travel. Additionally, adults with chronic medical conditions, such as diabetes or heart disease, may benefit from vaccines like the pneumococcal and hepatitis vaccines to prevent complications associated with these diseases. Individuals over 65 often receive a high-dose influenza vaccine and a pneumococcal vaccine series for enhanced protection against respiratory infections. The evolving landscape of infectious diseases and advancements in vaccine development underscore the need for ongoing research and public health efforts to optimize adult vaccination strategies.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France